- ►bloodjournal.org [PDF] DL White, VA Saunders, P Dang, J Engler, … - Blood, 2006 - Am Soc Hematology . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 118 - Related articles - BL Direct - All 6 versions
RH Falk - Circulation, 2005 - Am Heart Assoc Cardiac amyloidosis is a manifestation of one of several systemic diseases known
as the amyloidoses. 1,2 This uncommon disease is probably underdiagnosed, and
even when a diagnosis of amyloidosis of the heart is made, the fact that ... Cited by 105 - Related articles - All 7 versions
- ►bloodjournal.org [PDF] T Tammela, A Saaristo, M Lohela, T Morisada, … - Blood, 2005 - Am Soc Hematology . Hematology; all rights reserved Copyright 2007 by The American Society of 200,
Washington DC 20036. semimonthly by the American Society of Hematology, 1900 M
St, NW, Suite Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published Cited by 97 - Related articles - All 7 versions
- ►hematologylibrary.org [PDF] A Dispenzieri, MQ Lacy, JA Katzmann, SV … - Blood, 2006 - bloodjournal.hematologylibrary.org . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 78 - Related articles - BL Direct - All 9 versions
- ►bloodjournal.org G Palladini, V Perfetti, S Perlini, L Obici, F … - Blood, 2005 - Am Soc Hematology Based on the efficacy of thalidomide in multiple myeloma and on its synergy with
dexamethasone on myeloma plasma cells, we evaluated the combination of
thalidomide (100 mg/d, with 100-mg increments every 2 weeks, up to 400 mg) ... Cited by 72 - Related articles - All 8 versions
A Jaccard, P Moreau, V Leblond, X Leleu, L … - New England Journal of Medicine, 2007 - content.nejm.org From Centre Hospitalier Universitaire, Université et Centre National de la Re-
cherche Scientifique, UMR 6101, Limoges (AJ, FQ, MC); Centre Hospitalier Uni-
versitaire, Nantes (PM); Hôpital Pitié– Salpêtrière, Assistance ... Cited by 67 - Related articles - BL Direct - All 5 versions
- ►hematologylibrary.org [PDF] KT Kim, K Baird, JY Ahn, P Meltzer, M Lilly, M … - Blood, 2004 - bloodjournal.hematologylibrary.org . Hematology; all rights reserved Copyright 2007 by The American Society of 200,
Washington DC 20036. semimonthly by the American Society of Hematology, 1900 M
St, NW, Suite Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published Cited by 64 - Related articles - All 6 versions
- ►hematologylibrary.org G Palladini, F Lavatelli, P Russo, S Perlini, V … - Blood, 2006 - bloodjournal.hematologylibrary.org N-terminal natriuretic peptide type B (NT-proBNP) is a marker of cardiac
dysfunction in light chain amyloidosis (AL) and a powerful prognostic
determinant. Serum NT-proBNP and circulating free light chains (FLCs) were ... Cited by 62 - Related articles - BL Direct - All 7 versions
MA Gertz, MQ Lacy, A Dispenzieri, SM Ansell, … - Bone Marrow Transplantation, 2004 - nature.com High-dose chemotherapy and autologous stem cell transplantation are used
increasingly to treat patients with light-chain-related amyloidosis (AL).
Treatment-related mortality is approximately 15%. To enable more patients ... Cited by 52 - Related articles - BL Direct - All 3 versions
- ►bu.edu [PDF] B Ng, LH Connors, R Davidoff, M Skinner, RH … - Archives of internal medicine, 2005 - Am Med Assoc Background Small deposits of amyloid are often found in the hearts of elderly
patients. However, extensive deposition of transthyretin-derived amyloid fibrils
in the heart (senile systemic amyloidosis [SSA]) can cause heart failure. ... Cited by 55 - Related articles - BL Direct - All 11 versions
